期刊文献+

依那普利联合小剂量美托洛尔治疗收缩性心力衰竭对左室舒张末期内径及左室射血分数的影响 被引量:5

下载PDF
导出
摘要 目的探讨依那普利联合小剂量美托洛尔治疗收缩性心力衰竭(CHF)对左室舒张末期内径及左室射血分数的影响。方法120例CHF患者随机分为试验组和对照组,各60例。对照组应用常规药物(利尿剂、扩血管药物、洋地黄)治疗;治疗组在对照组治疗基础上加用依那普利和美托洛尔。均服用48周,尔后观察比较2组临床疗效、左室舒张末期内径(LVEDd)及左室射血分数(LNEF)的变化。结果试验组临床总有效率明显优于对照组(P<0.05);与对照组比较,试验组LVEDd缩小(P<0.05),LVEF增高(P<0.05)。结论依那普利联合小剂量美托洛尔治疗CHF临床疗效明显。
作者 韩丹娅
出处 《疑难病杂志》 CAS 2009年第12期731-732,共2页 Chinese Journal of Difficult and Complicated Cases
  • 相关文献

参考文献7

  • 1Moukarbel GV, Solomon SD. Early use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers:evidence from clinical trials [J]. Curr Heart Fail Rep,2008,5 (4) : 197-203.
  • 2Gusev K,Domenighetti AA, Delbridge LM, et al. Angiotensin II-mediated adaptive and maladaptive remodeling of cardiomyocyte excitation-contraction coupling [ J ]. Circ Res,2009,105 ( 1 ) :42-50.
  • 3Jin D, Takai S, Sugiyama T. Long-term angiotensin II blockade may improve not only hyperglycemia but also age-associated cardiac fibrosis [ J ]. J Pharmacol Sci ,2009,109 (2) :275-284.
  • 4Werner CM, Bohm M. The therapeutic rote of RAS blockade in chronic heart failure [J].Ther Adv Cardiovasc Dis,2008,2 ( 3 ) : 167-177.
  • 5Pilote L, Abrahamowicz M, Eisenberg M, et al. Effect of different angioten- sin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure [ J ]. CMAJ ,2008 ,178 ( 10 ) : 1303-1311.
  • 6Frankenstein L, Zugck C, Schellberg D, et al. Prevalence and prognostic significance of adrenergic escape during chronic beta-blocker therapy in chronic heart failure [J]. Eur J Heart Fail,2009,11 ( 2 ) : 178-184.
  • 7Tuncay E, Scymen AA, Sam P, et al. Effects of beta-adrenergic receptor blockers on cardiac function:a comparative study in male versus female rats [ J ]. Can J Physiol Pharmaco1,2009,87 (4) :310-317.

同被引文献30

  • 1赵静珊.依那普利联合氢氯噻嗪对原发性高血压疗效的临床观察[J].中国民族民间医药,2009,18(3):119-120. 被引量:7
  • 2刘力生.2004年中国高血压防治指南(实用本)[J].高血压杂志,2004,12(6):483-486. 被引量:368
  • 3詹红,Tse Hung-fat,曹晶茗,Lau Cpu-pak.不同左心室射血分数老年充血性心力衰竭患者药物治疗的临床研究[J].中国危重病急救医学,2006,18(4):210-215. 被引量:20
  • 4李鹏,赵焕军,郝兵.缬沙坦和依那普利治疗原发性高血压的对比研究[J].实用药物与临床,2006,9(3):143-144. 被引量:6
  • 5Gusev K, Domenighetti AA, Delbridge LM, et al. Angiotensin I1 -mediated adaptive and maladaptive remodeling of cardiomyocyte excitation-contraction coupling. Circ Res, 2009,105( 1 ) :42-50.
  • 6Werner CM, B~ hm M. The therapeutic role of RAS blockade in chronic heart failure. Ther Adv Cardiovasc Dis, 2008,2 (3) : 167- 177.
  • 7Pilote L, Abrahamowicz M, Eisenberg M, et al. Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure. CMAJ, 2008,178 (10): 1303-1311.
  • 8Frankenstein L, Zugck C, Schellberg D,et al. Prevalence and prognostic significance of adrenergic escape during chronic beta- blocker therapy in chronic heart failure. Eur J Heart Fail, 2009,11 (2): 178-184.
  • 9Malde B, Regalado J, Greenberger PA. Investigation of angioede- ma associated with the use of angiotensin-converting enzyme inhibi- tots and angiotensin receptor blockers. Ann Allergy Asthma Immu- nol,2007,98 ( 1 ) :57-63.
  • 10Symvoulakis EK, Kyrmizakis DE, Drivas EI, et al. Angiotensin- converting enzyme inhibitor (ACE-I)- and angiotensin receptor blocker (ARB)-related angioedema: a neg, lected issue in daily practice in Greece. Eur J Gen Pract,2007,13(4) :239-241.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部